Is an elevated soluble transferrin receptor consistent with iron deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, an elevated soluble transferrin receptor (sTfR) is consistent with iron deficiency.

An elevated soluble transferrin receptor is a reliable marker for iron deficiency and is particularly valuable because it remains elevated even in the presence of concurrent inflammation, unlike ferritin. 1

How sTfR Works in Iron Deficiency

The soluble transferrin receptor is a circulating protein derived from cleavage of the membrane transferrin receptor on erythroid precursor cells in the bone marrow. It is:

  • Inversely proportional to tissue iron availability - when iron stores are depleted, sTfR levels rise 1
  • A measure of erythropoietic activity - reflecting the body's increased demand for iron 1
  • Relatively unaffected by inflammation compared to other iron parameters like ferritin, making it especially useful when inflammation is present 1

Clinical Interpretation

In Straightforward Cases

In the absence of inflammation, elevated sTfR combined with low iron, low ferritin, and low transferrin saturation confirms iron deficiency 2

In Complex Cases with Inflammation

This is where sTfR truly shines. When inflammation is present, ferritin can be falsely elevated or normalized, masking iron deficiency. In these situations:

  • sTfR remains elevated in true iron deficiency even with concurrent inflammation 1
  • The sTfR-ferritin index (sTfR/log₁₀ferritin) >2 is consistent with iron deficiency 1
  • An sTfR-ferritin index <1 suggests anemia of chronic inflammation without iron deficiency 1

This makes sTfR particularly valuable in children with chronic inflammatory conditions, inflammatory bowel disease, chronic kidney disease, and other conditions where inflammation complicates diagnosis 1, 2.

Important Caveats

sTfR is NOT reliable in patients with hemolytic anemia 1, as the increased erythropoietic activity from hemolysis will falsely elevate sTfR independent of iron status.

The test has limitations including:

  • Lack of widespread availability in many laboratories 1
  • Lack of published norms in healthy children 1
  • Can be elevated in conditions with increased erythropoietic drive (thalassemias, hemoglobinopathies) 3

Diagnostic Algorithm

When evaluating for iron deficiency:

  1. Without inflammation: Use ferritin as primary marker (≤20 ng/mL in children, ≤30 ng/mL in menstruating individuals indicates iron deficiency) 1

  2. With inflammation or when ferritin is equivocal (30-100 ng/mL): Order sTfR 1, 2

    • Elevated sTfR confirms iron deficiency
    • Calculate sTfR-ferritin index if available
    • Index >2 = iron deficiency
    • Index <1 = anemia of chronic disease without iron deficiency
  3. Exclude hemolytic anemia before relying on sTfR 1

The evidence consistently demonstrates that elevated sTfR is a valid and specific marker for iron deficiency, with particular utility in distinguishing iron deficiency from anemia of chronic inflammation 2, 4, 5, 6.

Related Questions

What is the likely diagnosis and recommended treatment for a patient with mild normocytic anemia, low ferritin, high serum iron, elevated total iron‑binding capacity, and high transferrin?
For a 12-year-old with mild anemia (hemoglobin 11.7 g/dL, hematocrit 34.9 %), ferritin 74 ng/mL, serum iron 132 µg/dL, transferrin 378 mg/dL, transferrin saturation 26 %, and total iron‑binding capacity 504 µg/dL, should I continue the current oral ferrous sulfate (≈3 mg/kg elemental iron once daily) for the full 12‑week course?
In a patient with hemoglobin 11.1 g/dL, serum iron 142 µg/dL, total iron‑binding capacity 400 µg/dL, and transferrin saturation 36%, what is the likely cause of the anemia and what further evaluation is recommended?
How should I manage a patient with normal CBC and chemistry but borderline low iron studies (low serum iron, normal TIBC, transferrin saturation 18%, ferritin 33 ng/mL) and vitamin D deficiency (25‑OH‑vitamin D 18 ng/mL)?
In an 18‑year‑old female with severe anemia (hemoglobin approximately 6.5 g/dL) and elevated ferritin, who has no other symptoms, what is the appropriate immediate management and diagnostic work‑up?
What are the recommended treatment options for sexual arousal disorder in women?
What is the appropriate cyclosporine dosing for a 22 kg child with atopic dermatitis?
What oral systemic treatment options and dosing are recommended for a 22 kg child with moderate‑to‑severe atopic dermatitis after optimized topical therapy has failed?
What alternative selective serotonin reuptake inhibitors can be used instead of sertraline for a patient taking methylphenidate 72 mg daily?
What is the appropriate digoxin maintenance dose after a standard intravenous loading dose in an adult with normal renal function, and how should the dose be adjusted for elderly patients or those with impaired renal function?
When should opportunistic infections be suspected in patients receiving rituximab?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.